Genetic and Molecular Analysis of Mouse Mutants with Congenital Heart Defects
Genetic and Molecular Analysis of Mouse Mutants with Congenital Heart Defects
批准号:
7654786
负责人:
Ivan Paul Moskowitz
金额:
$39.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2014-06-30
关键词:
Atrial Heart Septal DefectsCardiacCarrier ProteinsCellsComplementCongenital Heart DefectsDefectDevelopmentEmbryoErinaceidaeEventGenesGeneticGoalsGrantGrowthHeartHeart AtriumHeart Septal DefectsHumanLaboratoriesLightMapsMolecularMolecular AnalysisMutant Strains MiceMutationPathway interactionsPhenotypePositioning AttributeProteinsPulmonary CirculationReagentRoleSignal TransductionSpecific qualifier valueStem cellsTransgenic OrganismsWorkbasebody systemcongenital heart disordermutantnovelpositional cloningprogenitorpublic health relevancesmoothened signaling pathwaytranscription factor
中文摘要
描述(由申请人提供):房间隔是分离四足动物体循环和肺循环的关键步骤,房间隔缺损是人类先天性心脏病(CHD)最常见的形式。本项目的目的是研究房间隔和房间隔祖细胞特化所需的细胞和分子机制。房间隔的经典观点是基于心内形态发生事件。然而,我们实验室和其他实验室的最近工作已经产生了一种基于第二心脏场的贡献的心房分隔的新范例(Mommersteeg等人,2006; Snarr等人,2007 b; Goddeeris等人,2008年)。我们已经确定了一个心脏祖细胞亚群的房间隔特异性。后第二心脏区域的Hedgehog信号标记房间隔祖细胞。这些发现意味着房间隔与非房间隔细胞的命运是在祖细胞特化的水平上区分的,而不是通过随后在发育中的心房内获得的位置信息来区分的。这些新特征的祖细胞被指定并产生房间隔的分子机制目前尚不清楚。在这里,我们提出了一个综合的方法,使用正向和反向遗传学建立一个心房间隔所需的分子通路,并调查房间隔祖细胞的规格。我们的具体目标是(1)分析野生型和Hedgehog信号突变胚胎中房间隔祖细胞的特化、增殖和存活;(2)分析cac 2突变小鼠中的房间隔祖细胞和Hh信号;(3)鉴定cac 2的分子基础,cac 2是房间隔形成所需的一种新基因。授予期结束时,将提供对房间隔祖细胞规格和功能的分子基础的更好理解。这项工作将有助于我们对心脏间隔缺损个体发生的理解的一个正在进行的范式转变。公共卫生相关性:房间隔是分离四足动物体循环和肺循环的关键步骤,房间隔缺损是人类先天性心脏病最常见的形式之一。该项目的目的是更好地了解房间隔祖细胞的规格和功能。这项工作的长期目标是了解房间隔缺损的个体发生。
英文摘要
DESCRIPTION (provided by applicant): Atrial septation is a critical step in separating the systemic and pulmonary circulations in tetrapods and atrial septal defects are among the most common forms of human congenital heart disease (CHD). The objective of this project is to investigate the cellular and molecular mechanisms required for atrial septation and atrial septal progenitor cell specification. The canonical view of atrial septation is based on intracardiac morphogenetic events. However, recent work in our laboratory and others has engendered a novel paradigm for atrial septation, based on contributions from the second heart field (Mommersteeg et al., 2006; Snarr et al., 2007b; Goddeeris et al., 2008). We have identified a subset of cardiac progenitor cells specific for the atrial septum. Hedgehog signaling in the posterior second heart field marks atrial septal progenitors. These findings imply that atrial septum vs. non-septum cell fate is distinguished at the level of progenitor cell specification rather than by positional information acquired subsequently within the developing atrium. The molecular mechanisms by which these newly characterized progenitor cells are specified and generate the atrial septum are currently unknown. Here, we propose an integrative approach using both forward and reverse genetics to build a molecular pathway required for atrial septation and investigate the specification of atrial septal progenitors. Our specific aims are to (1) Analyze the specification, proliferation, and survival of atrial septal progenitors in wild-type and Hedgehog signaling mutant embryos; (2) Analyze atrial septal progenitors and Hh signaling in cac2 mutant mice; and (3) Identify the molecular basis of cac2, a novel gene required for atrial septation. A greater understanding of the molecular basis of atrial septal progenitor cell specification and function will be delivered at the end of the granting period. This work will contribute to an ongoing paradigm shift in our understanding of the ontogeny of cardiac septal defects. PUBLIC HEALTH RELEVANCE: Atrial septation is a critical step in separating the systemic and pulmonary circulations in tetrapods and atrial septal defects are among the most common forms of human congenital heart disease. The objective of this project is to gain a better understanding of atrial septal progenitor cell specification and function. The long- term goal of this work is to understand the ontogeny of atrial septal defects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A heterochronic model for birth defects in Down Syndrome
-
批准号:10658360
-
项目类别:
-
资助金额:$503.5万
-
财政年份:2023
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Evaluation of Hedgehog signaling-dependent heart development in a mouse model of Down Syndrome
-
批准号:10747227
-
项目类别:
-
资助金额:$44.6万
-
财政年份:2022
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Gene Expression Networks for Human Cardiac Differentiation in Down Syndrome
-
批准号:10251345
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2020
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Gene Expression Networks for Human Cardiac Differentiation in Down Syndrome
-
批准号:10057128
-
项目类别:
-
资助金额:$15.6万
-
财政年份:2020
-
负责人:Ivan Paul Moskowitz
-
依托单位:
The molecular basis of cardiac differentiation control
-
批准号:10237139
-
项目类别:
-
资助金额:$61.16万
-
财政年份:2019
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Gene Regulatory Non-Coding RNAs in the Human Heart
-
批准号:10223926
-
项目类别:
-
资助金额:$56.54万
-
财政年份:2019
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Gene Regulatory Non-Coding RNAs in the Human Heart
-
批准号:10460639
-
项目类别:
-
资助金额:$55.51万
-
财政年份:2019
-
负责人:Ivan Paul Moskowitz
-
依托单位:
The molecular basis of cardiac differentiation control
-
批准号:9766033
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2019
-
负责人:Ivan Paul Moskowitz
-
依托单位:
The molecular basis of cardiac differentiation control
-
批准号:10460174
-
项目类别:
-
资助金额:$57.45万
-
财政年份:2019
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Gene Regulatory Non-Coding RNAs in the Human Heart
-
批准号:9803245
-
项目类别:
-
资助金额:$58.02万
-
财政年份:2019
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Functional Assays to Screen Genomic Hits
-
批准号:9502340
-
项目类别:
-
资助金额:$49.65万
-
财政年份:2014
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Functional Assays to Screen Genomic Hits
-
批准号:8757695
-
项目类别:
-
资助金额:$19.84万
-
财政年份:2014
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Etiology of Congenital Heart Disease in Down Syndrome
-
批准号:8783933
-
项目类别:
-
资助金额:$68.4万
-
财政年份:2014
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Functional Assays to Screen Genomic Hits
-
批准号:9306932
-
项目类别:
-
资助金额:$50.51万
-
财政年份:2014
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Etiology of Congenital Heart Disease in Down Syndrome
-
批准号:9323502
-
项目类别:
-
资助金额:$69.03万
-
财政年份:2014
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Transcriptional Control of Cardiac Conduction System Function by T-box Genes
-
批准号:8645732
-
项目类别:
-
资助金额:$49.9万
-
财政年份:2012
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Transcriptional Control of Cardiac Conduction System Function by T-box Genes
-
批准号:8450762
-
项目类别:
-
资助金额:$49.22万
-
财政年份:2012
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Transcriptional Control of Cardiac Conduction System Function by T-box Genes
-
批准号:9045693
-
项目类别:
-
资助金额:$48.75万
-
财政年份:2012
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Transcriptional Control of Cardiac Conduction System Function by T-box Genes
-
批准号:8828285
-
项目类别:
-
资助金额:$48.78万
-
财政年份:2012
-
负责人:Ivan Paul Moskowitz
-
依托单位:
Transcriptional Control of Cardiac Conduction System Function by T-box Genes
-
批准号:8287442
-
项目类别:
-
资助金额:$58.58万
-
财政年份:2012
-
负责人:Ivan Paul Moskowitz
-
依托单位:
海外基金